Bristol-Myers Squibb (BMY) Reports In-Line Q2 EPS, Updates FY EPS Guidance
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $64.69 -3.19%
Revenue Growth %: +3.2%
Financial Fact:
Total Expenses: 3.36B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +3.2%
Financial Fact:
Total Expenses: 3.36B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $0.74, in-line with the analyst estimate of $0.74. Revenue for the quarter came in at $5.14 billion versus the consensus estimate of $5.09 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2017 EPS of $2.90-$3.00, versus the consensus of $2.95.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- GameStop (GME) Tops Q2 EPS by 8c
- HSBC Raises S&P500 Target to 8,100
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
